tiprankstipranks
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
US Market

Bioxytran (BIXT) Financial Statements

14 Followers

Bioxytran Financial Overview

Bioxytran's market cap is currently ―. The company's EPS TTM is $-0.03; its P/E ratio is -3.88; Bioxytran is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 613.19K$ -1.07M$ -987.27K$ -1.37M$ -885.20K
EBITDA$ 615.22K$ -1.06M-$ -1.02M$ -884.68K
Net Income Common Stockholders$ -800.33K$ -1.08M$ -1.00M$ -1.41M$ 850.87K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.02K$ 26.09K$ 80.27K$ 45.18K$ 153.80K
Total Assets$ 125.54K$ 137.64K$ 189.04K$ 143.06K$ 233.53K
Total Debt$ 861.50K$ 1.90M$ 1.90M$ 2.00M$ 2.17M
Net Debt$ 851.48K$ 1.87M$ 1.82M$ 1.95M$ 2.01M
Total Liabilities$ 1.12M$ 3.25M$ 2.33M$ 2.77M$ 4.29M
Stockholders Equity$ -296.15K$ -2.43M$ -1.48M$ -2.00M$ -3.44M
Cash Flow-
Free Cash Flow$ -81.56K$ -99.19K-$ -173.62K$ -191.60K
Operating Cash Flow$ -75.57K$ -92.63K$ -342.58K$ -153.28K$ -186.89K
Investing Cash Flow$ -6.00K$ -6.56K$ -12.69K$ -20.34K$ -4.71K
Financing Cash Flow$ 65.50K$ 45.00K$ 390.36K$ 65.00K$ 50.00K
Currency in USD

Bioxytran Earnings and Revenue History

Bioxytran Debt to Assets

Bioxytran Cash Flow

Bioxytran Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis